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Vertebrate members of the ski/snoN family of proto-oncogenes antagonize TGFβ and BMP signaling in a variety of experimental situations.
This activity of Ski/SnoN proteins is related to their ability to interact with Smads, the proteins acting as key mediators of the transcriptional
response to the TGFβ superfamily members. However, despite extensive efforts to identify the physiological roles of the Ski/SnoN proteins, it is
not yet clear whether they participate in regulating Activin and/or BMP signaling during normal development. It is therefore crucial to examine
their roles in vivo mostly because of the large number of known Ski/SnoN-interacting proteins and the association between the up-regulation of
these genes and cancer progression. Here we characterize the Drosophila homolog to vertebrate ski and snoN genes. The Drosophila dSnoN
protein retains the ability of its vertebrate counterparts to antagonize BMP signaling in vivo and in cultured cells. dSnoN does not interfere with
Mad phosphorylation but it interacts genetically with Mad, Medea and dSmad2. Mutations in either the Smad2–3 or Smad4 putative binding sites
of dSnoN prevent the antagonism of dSnoN towards Dpp signaling, although homozygous flies for these mutations or for a genetic deficiency of
the locus are viable and have wings of normal size and pattern.
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Decapentaplegic (Dpp), a member of the TGFβ/BMP
family, plays essential roles during Drosophila embryonic and
imaginal development, influencing cell fate choices, cell
proliferation and differentiation (Gelbart, 1989). The core
elements of the pathway include the ligand Dpp, the type I
and II transmembrane receptors Thick veins (Tkv) and Punt
(Pnt), and the intracellular transducers Mothers against Dpp
(Mad, related to Smad1–5) and Medea (Med, related to Smad4)
(for reviews see Affolter et al., 2001; Feng and Derynck, 2005;
Massague and Wotton, 2000). Additional key components of
the pathway are the transcription factors Brinker (Brk) and
Schnurri (Shn) and the antagonist Daughters against Dpp (Dad),⁎ Corresponding author. Fax: +34 91 4978632.
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doi:10.1016/j.ydbio.2007.02.039related to vertebrate Smad7 (Marty et al., 2000; Tsuneizumi
et al., 1997). Drosophila also has a TGFβ/Activin pathway,
involved in the control of cell growth during imaginal
development, in which the ligand Activin binds the type I
receptor Baboon (Babo) that phosphorylates dSmad2 (Brummel
et al., 1999). The structure of these pathways is conserved and
the mechanism of signal transduction is similar between
vertebrates and invertebrates (Massague and Chen, 2000). In
both pathways, binding of the ligand to receptor complexes
triggers receptor activation, which leads to the phosphorylation
of Mad (Tkv/Dpp) or dSmad2 (Babo/Activin). Once phos-
phorylated, Mad or dSmad2 interacts with Med, forming
complexes that translocate to the nucleus where they can
interact with DNA and, in combination with a number of
cofactors, regulate the transcription of their target genes
(Wisotzkey et al., 1998). Transcriptional regulation mediated
by Mad/Med complexes depends on the cell-type-specific
cofactors recruited to the DNA. For instance, in combination
with Shn, Mad/Med negatively regulate the expression of the
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Brk, in turn, can recruit several corepressor complexes to the
DNA, regulating negatively the transcription of target genes
bearing Brk-binding sequences. In essence, the response of a
target gene to Dpp signaling is determined both by the
combination of Mad/Med and Brk with specific co-regulators
and by the structure of the regulatory DNA regions bound by
them (Barrio and de Celis, 2004; Kirkpatrick et al., 2001; Saller
and Bienz, 2001; Winter and Campbell, 2004).
A variety of mechanisms regulate the activity of the Dpp
pathway, including negative feedbacks that contribute to signal
termination mediated by the E3-Ubiquitin ligase dSmurf and the
antagonist effect of Dad. dSmurf interacts with activated Mad,
triggering its degradation by the proteasome (Liang et al., 2003;
Podos et al., 2001). In contrast, Dad, itself a Dpp target gene,
interferes with the phosphorylation of Mad through interaction
with the Dpp receptor complex (Inoue et al., 1998; Tsuneizumi
et al., 1997). The TGFβ pathway has been widely studied in
vertebrates, where it regulates a variety of physiological
responses including growth inhibition, differentiation and
induction of apoptosis (Massague et al., 2000). Major negative
regulators of the TGFβ response are the proteins of the Ski/
SnoN family, identified by their ability to induce morphological
transformation in chicken and quail embryo fibroblasts and
terminal muscle differentiation in quail embryo cells (Li et al.,
1986; Stavnezer et al., 1986).
The Ski/SnoN proteins appear to antagonize TGFβ sig-
naling using different cell-type-specific mechanisms. First,
Ski/SnoN, acting in the nucleus, displace the Smad co-
activators p300/CBP and recruit the corepressors N-CoR/
SMRT and mSin3A, forming macromolecular complexes with
the histone deacetylase complex (HDAC) (Nomura et al.,
1999). In this manner, in the presence of high levels of Ski/
SnoN, gene expression is not activated in response to TGFβ
signaling. Second, and to account for Ski/SnoN augmented
DNA binding of Smad complexes in the absence of receptor
activation, it was proposed that Ski/SnoN stabilize inactive
Smad complexes bound to the DNA, explaining the ability of
these proteins to antagonize TGFβ signaling by promoting
gene expression (Luo et al., 1999; Sun et al., 1999). Finally,
Ski/SnoN, acting in the cytoplasm, can interfere and reduce the
ligand-dependent phosphorylation of Smad2/3, preventing
their translocation to the nucleus (Prunier et al., 2003). The
interaction of Ski/SnoN with Smad4 and Smad2/3 or Smad1/5
occurs through two independent domains of the Ski/SnoN
protein (Wang et al., 2000; He et al., 2003; Ueki and Hayman,
2003; Wu et al., 2002). The relationships between Ski/SnoN
and TGFβ signaling have been primarily studied in experi-
mental conditions of increased expression of these proteins, a
situation that relates mainly to the progression of a large
number of human tumors, where high levels of Ski/SnoN
proteins are usually associated with poor clinical prognosis
(Buess et al., 2004).
In addition to the Smads, several other Ski-interacting
proteins have been identified in biochemical assays. Thus, Ski
interacts with GATA1 and blocks the binding of GATA1 to
DNA in a TGFβ signaling-independent manner (Ueki et al.,2004). Ski also interacts with c-Myb to negatively regulate its
activity by recruiting HDAC complexes to the DNA (Nomura
et al., 2004). In a similar manner, c-Ski is required for the
transcriptional repression mediated by Retinoblastoma (Rb),
which binds directly to c-Ski and HDAC (Prathapam et al.,
2002; Tokitou et al., 1999). Ski also associates with the Retinoic
Acid Receptor complex and can repress transcription from a
Retinoic Acid Response Element (Ritter et al., 2006). Finally,
Ski has also been found in association with other cellular
proteins not related to transcriptional control, such as α-tubulin
in the mitotic spindle and centrosomal proteins (Marcelain and
Hayman, 2005).
The physiological roles of Ski/SnoN have also been analyzed
in vivo by studying knockout mice deficient for the ski or snoN
genes. Contradictory results have been reported because one
snoN-null line shows embryonic lethality before E3.5 (Shina-
gawa et al., 2000) and two other snoN deletions are viable and
show defects only in T cell activation (Pearson-White and
McDuffie, 2003). In any case, it is not clear whether the
observed phenotypes are related to a lack of repression of TGFβ
signaling. Similarly, it is also not clear whether the typical
abnormalities of ski-deficient mice, such as neural tube defects,
postaxial polydactyly and eye defects, are related to TGFβ
activity (Berk et al., 1997; Colmenares et al., 2002). Finally,
HKC cells after transfection with snoN specific siRNA
displayed a greater responsiveness to TGFβ-1 stimulation,
suggesting that down-regulation of snoN lowers the threshold
of TGFβ-1 responsiveness (Yang et al., 2003).
In this work, we describe the genetic and functional cha-
racterization of the Drosophila gene dsnoN, an orthologue of
both vertebrate ski and snoN. To thoroughly analyze the
relation between dSnoN and the TGFβ pathway, we have
chosen the wing imaginal disc as experimental system. The
wing disc is the epithelium that gives rise to the thorax and
wing of the fly, and the role of both Dpp and Activin signaling
in the control of growth and patterning of the disc has been
carefully studied (Brummel et al., 1999; Zecca et al., 1995).
We identified dsnoN in an over-expression screen aimed to
identify genes affecting the differentiation of the veins (Molnar
et al., 2006) and found that increased expression of dsnoN
causes phenotypes reminiscent of loss of Dpp activity in the
adult wing, legs and thorax. These phenotypes are associated
with the failure of Dpp to regulate the expression of its target
genes in the presence of high levels of dSnoN, a situation that
mirrors the relations between vertebrate Ski/SnoN and the
TGFβ signaling pathway. The augmented expression of
dSnoN does not interfere with Mad phosphorylation, and its
effect is completely abolished by mutations in the putative
Smad2–3 or Smad4-binding regions of dSnoN. Surprisingly,
we did not find a significant phenotype in the wing upon
removal of dsnoN, and therefore we suggest that during
normal wing development the contribution of several over-
lapping mechanisms might make redundant a role for dsnoN
to regulate Dpp signaling. In dSnoN over-expression condi-
tions, the interaction between dSnoN and Mad/Med cannot be
relieved by pathway activation, and the transcriptional
regulation of Dpp target genes is compromised.
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Drosophila melanogaster strains and phenotypic analysis
We isolated one P-GS insertion in the 5′ UTR of CG7233 (GS-M67) in a
mutagenesis screen designed to identify genes affecting vein differentiation
(Molnar et al., 2006). We used the following Drosophila UAS lines: UAS-tkvQD
(Nellen et al., 1996), UAS-dpp (Staehling-Hampton and Hoffmann, 1994),
UAS-brk, UAS-Mad, UAS-Med, UAS-baboact, UAS-dSmad2 and UAS-GFP (Ito
et al., 1997). We also used the Gal4 lines Gal4-dll, Gal4-nub, Gal4-sal, Gal4-
638 and Gal4-253 (Calleja et al., 1996; de Celis et al., 1999) and the P-lacZ
reporter lines dad-lacZ, brk-lacZ, tkv-lacZ and omb-lacZ. All stocks not
described in the text can be found in Flybase (http://www.flybase.net/). All
phenotypes were analyzed at 25 °C, and flies were mounted for microscopic
examination in lactic acid–ethanol (1:1). Pictures were taken in an Axiophot
microscope with a Spot digital camera and processed using Adobe Photoshop.
Generation of dsnoN alleles by chemical mutagenesis
Loss of function alleles were induced by chemical mutagenesis, treating
isogenic males of w; GS-M67/GS-M67 genotype with 20 mM ENU, according
to Lewis and Bacher (1968). Treated males were mass-crossed with Gal4-638
females and viable progeny of genotype Gal4-638; GS-M67/+ were isolated to
make the stocks w; GS-M67-rev/CyO. The Gal4-638; GS-M67/+ males do not
hatch from the pupal case, and the sibling females (Gal4-638/+; GS-M67/+)
display a strong reduction in wing size and elimination of wing pattern elements.
Among 15,000 progeny (counting viable females with wing size reduction
phenotype) we isolated three complete revertants, named GS-M672c3, GS-
M673K1 and GS-M673W1, and six partial revertants, GS-M671D1, GS-M67F3,
GS-M67S2, GS-M67V2 GS-M67K2 and GS-M67R102. The presence of mutations
in all revertants was confirmed by sequencing the coding region of dsnoN (see
Fig. 6 and Supplementary material and methods).
Generation of a dsnoN deficiency by FRT-mediated recombination
We used the Exelixis flanking insertions f00844 and d02797 (Parks et al.,
2004) separated by 65 kb including dsnoNS and CG7231, as well as most of
dsnoNL and CG7228 coding regions (see Supplementary Fig. 1). FRT
recombination was induced by a daily 1 h heat shock at 37 °C to the progeny
of hsFLP1.22/+; f00844/d02797 females and w; CyO/If males. Forty putative
f00844-d02797/CyO offspring males were individually crossed to w,CyO/If
females and after 3 days were used to extract genomic DNA to confirm by PCR
the existence of FRT recombination (Parks et al., 2004). We used f00844 and
d02797 oligos as well as dSnoN-specific oligos to confirm the presence of the
deficiency, which we refer to as Df(2L)snoN (see Supplementary Fig. 1).
cDNA isolation and generation of dsnoNS constructs
cDNAs 3.2 and 202 were isolated from a 12–24 h embryonic library (Brown
and Kafatos, 1988) by PCR. For cDNA3.2 we used the primer M67.3, which
corresponds to the predicted gene CG7233 (Flybase), in combination with
primer G2A from the library vector pNB40. For cDNA202 we used the primers
(−)399 and G2B. cDNA 7.1 was isolated from an imaginal disc library (Brown
and Kafatos, 1988) using primers M67.3 and G2A. PCR fragments were cloned
in the pSTBlue-1 vector (Novagen) and sequenced. cDNAs 3.2 and 7.1 were not
complete in the 5′ ends, and cDNAs 3.2 and 202 were incomplete in their 3′
ends. Accession numbers are: cDNA7.1, AM282580; cDNA3.2, AM282581;
cDNA202, AM282582. The generation of UAS and RNAi constructs for
dsnoN is detailed in Supplementary material and methods.
Tissue culture, transfection, immunocytochemistry and reporter assays
Mouse embryonic carcinoma P19 cells (ATCC) were grown in α-MEMwith
ribonucleosides and deoxyribonucleosides, supplemented with 7.5% bovine calf
serum and 2.5% fetal bovine serum (Gibco BRL) and Cos1 cells were
maintained in D-MEM with L-glutamine, sodium bicarbonate and glucose,
supplemented with 10% fetal bovine serum (Gibco BRL). Cells weretransformed in 24 well plates using calcium chloride and Lipofectamine 2000
(Invitrogen). Plasmids used for transformation were pRL (Promega) and Flag-
Mad, HA-Med, HA-Tkv* and TLX2-Lux, all cloned in pCMV5B vector, kindly
provided by J. Wrana (Brummel et al., 1999). The constructions dsnoNS-GFP,
dsnoNSΔC-GFP and dsnoNL-GFP under the CMV promoter were as described
above. For immunohistochemistry, Cos1 cells were grown on coverslips, fixed
with paraformaldehyde 4% and stained with mouse monoclonal anti-Ha 12CA5
(dilution 1:200; Sigma) and rabbit anti-Flag antibodies (dilution 1:2000; Sigma)
using standard procedures. DAPI (Roche) was used as nuclear marker. Samples
were analyzed in a Leica confocal microscope.
For Luciferase assays in P19 cells we used the Dual-Luciferase Reporter
Assay System (Promega) with Renilla luciferase as a control. Viability assays in
P19 cells were done using CellTiter-Glo (Promega). Luminescence measure-
ments were done in a plate reader (Veritas). Average, standard deviation and P
values for each condition originate from at least 20 independent experiments and
were calculated using Microsoft Excel.
Drosophila inmunocytochemistry and in situ hybridization
We used mouse monoclonals anti-DSRF and anti-osa (Hybridoma bank) and
rabbit anti-Sal (dilution 1:200) (Barrio et al., 1999), anti-phospho-Histone3
(dilution 1:200; Upstate Biotech) and anti-βGal (dilution 1:200; Cappel).
Secondary antibodies were from Jackson Immunological Laboratories (used at
1:200 dilution). Third instar imaginal discs were dissected, fixed and stained as
described in de Celis (1997). Confocal images were captured using a BioRad
confocal microscope. In situ hybridization in imaginal discs was carried out as
previously described (de Celis, 1997). Sense and anti-sense digoxigenin-labeled
RNA probes were prepared with T7, T3 or SP6 RNA polymerases using the
following clones as templates: pST-CG7233, cDNA3.2, pST-SD16909, pST-
GH22035, pST-GH28093, pST-7093, pST-11093 and RE22593.Results
Ectopic expression of dsnoN causes loss of Dpp signaling
Genetic combinations between the P-GS insertion GS-M67
and a variety of Gal4 lines expressed in the imaginal discs result
in striking adult phenotypes (Fig. 1). The modifications
observed in the wing vary, depending on the particular Gal4
line, from moderate wing size reduction and vein loss (Gal4-sal/
GS-M67; Fig. 1B) to strong wing size decrease accompanied by
the absence of all veins (Figs. 1C–D; nub-Gal4/GS-M67 and
638-Gal4/+; GS-M67/+). In the thorax, the combinations ptc-
Gal4/GS-M67 and pnr-Gal4/GS-M67 display a complete failure
in the closure between the two heminota (Fig. 1I and data not
shown), whereas in the legs the combination dll-Gal4/GS-M67
shows failures in anterior–posterior leg patterning and the
absence of distal segments (Fig. 1K). Interestingly, all these
phenotypes are similar to those caused by the reduction in dpp
expression or signaling (Fig. 1E and see Campbell et al., 1993;
de Celis, 1997). These facts suggest that the gene/s targeted by
the GS-M67 insertion interfere negatively with some aspect of
the Dpp signaling pathway.
The GS-M67 insertion is localized between the 5′ regions of
two annotated genes, CG7233 and CG7231 (Fig. 2). Because
the P-GS element carries UAS sequences at both ends, both
genes can be simultaneously expressed in GS-M67/Gal4
combinations (Molnar et al., 2006; Toba et al., 1999), and this
is indeed what we observed (Fig. 2D and data not shown for
CG7231). To identify unambiguously the gene responsible for
the ectopic expression phenotypes, we generated UAS and
Fig. 1. Wing phenotypes caused by increased expression of dsnoN. (A) Wild-type wing showing the longitudinal veins (LII–LV). (B–D) Adult wings of genetic
combinations between the P-GS insertion GS-M67 and the Gal4 lines Gal4-sal (B), Gal4-nub (C) and Gal4-638 (D). (E) Homozygous dppd5 wings. (F) Adult wing of
Gal4-sal/UAS-idsnoNS; GS-M67/+ genotype, showing a complete suppression of the GS-M67 phenotype shown in panel B. (G) Adult wing of Gal4-nub/UAS-
dsnoNS genotype, compare with panel C. (H) Wild-type notum. (I) Gal4-ptc/GS-M67 notum, showing a failure to close the two heminota (black arrow). (J) Wild-type
legs. (K) Gal4-dll/GS-M67 legs, showing distal truncations characteristic of dppdisc alleles. All wings, notum and legs correspond to female flies, and pictures were
taken at the same magnification.
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and CG7231. We found that only the over-expression of
CG7233 reproduces the phenotype of the GS-M67 insertion
(Fig. 1G and data not shown). Likewise, only the UAS-
CG7233i line is able to suppress the phenotype of GS-M67/
Gal4 combinations (Fig. 1F and data not shown). These data
indicate that the misexpression of CG7233 accounts for all the
phenotypes observed in combinations involving GS-M67.
Furthermore, some suppressors of the GS-M67 phenotype are
characterized by amino acid changes in the CG7233 coding
region (see below), further confirming its association with the
GS-M67 misexpression phenotypes.
Genomic structure and RNA expression of dsnoN
The gene CG7233, as annotated in Flybase, is formed by a
unique exon with an open reading frame of 1017 bp with no EST
clone associated (Fig. 2A). Therefore, we searched for cDNA
clones containing the CG7233 sequence by PCR in cDNA
libraries constructed from embryonic and imaginal polyA+ RNA
(Brown and Kafatos, 1988). We identified two polyA+ cDNAs
expressed throughout development, named cDNA3.2 and
cDNA7.1 (Fig. 2A, gray lines). cDNA7.1 includes CG7233,
whereas cDNA3.2 includes in addition part of CG7093, a gene
annotated proximal to CG7233 (Fig. 2A). These data indicatethat dsnoN generates, at least, two alternative transcripts, which
we named dsnoN-Short (CG7233; dsnoNS) and dsnoN-Long
(CG7233 plus CG7093; dsnoNL). Thus, the intergenic region
between CG7233 and CG7093 corresponds to a long intron of
80 kb. To verify the existence of this intron, we performed RT-
PCR reactions using mRNA from embryos, larvae and wing
imaginal discs and sets of primers specific for CG7233 (a),
CG7093 (c) and the joint between the two of them (b) (Fig. 2A).
Our results corroborated the existence of alternative splicing
(Fig. 2B). Interestingly, the same genomic organization was
found in D. pseudoobscura (not shown) and A. gambiae (Fig.
2C).Wewere not able to detect sequences clearly homologous to
CG7093 in other species. A recent publication by Takaesu et al.
(2006) also reported the existence of the long isoform, and the
authors found a certain degree of homology between CG7093
(corresponding to the C-terminal part of dSnoN-Long) and the
C-terminal part of human hSnoN. However, when this region is
compared to their Drosophila and mosquito homologues, we
found that the boxes conserved in insects do not coincide with
the sequences conserved between dSnoN-Long and hSnoN
(Supplementary Fig. 2).
By means of in situ hybridization using probes for the
common region of dsnoNS and dsnoNL and for the unique exon
of dsnoNL, we found that both transcripts are expressed under
UAS control in combinations between GS-M67 and Gal4 lines
Fig. 2. Molecular analysis and expression of dsnoN. (A) Schematic representation of the genomic region 28D2-D3 according to Flybase. Blue boxes represent
predicted ORFs and green boxes represent ESTs. The red triangle indicates the insertion site of GS-M67. The two dsnoN isoforms, dsnoNS and dsnoNL, are indicated
by red arrows. The newly identified cDNAs (cDNA7.1, cDNA3.2 and cDNA202) are indicated by gray lines. a, b and c indicate the position of the pairs of primers
used in the RT-PCR reactions shown in panel B. (B) RT-PCR products using the pairs of primers a, b and c from D. melanogaster embryonic (E), third instar larvae
(L3) and wing imaginal discs (wd) mRNAs. The asterisk indicates the amplified bands. Rp49 amplification was used as control. (C) PCR using A. gambiae cDNA
library as template and specific a, b and c pairs of primers. (D) In situ hybridization using anti-sense RNA probes for dsnoNS (7233) or dsnoNL (7093) transcripts,
either on wild-type (WT) or GS-M67/+; Gal4-sal/+ (M67) third instar wing imaginal discs. The color reaction was stopped before the endogenous expression
appeared in the two left discs to prevent over-staining.
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causally related only to the misexpression of dsnoNS because
the UAS-dsnoNL in combination with several Gal4 lines did not
affect adult patterning or growth (data not shown). In wild-type
imaginal discs the expression of both dsnoNS and dsnoNL is
generalized (Fig. 2D for the wing disc and data not shown).
dsnoNS contains a Ski domain, present in the ski/snoN
family of proto-oncogenes, and it has been identified as the
Drosophila snoN orthologue (Flybase). However, our phylo-
genetic analysis suggests that dSnoN is equidistant from the Ski
and SnoN vertebrate paralogues. For this reason, dsnoNS was
called previously Snowski by da Graca et al. (Fig. 3A; da Graca
et al., 2004). Other proteins containing Ski domains are grouped
in two distinct families, represented by Dachshund (Dac) and
CG11093 (Fig. 3A). Dac proteins are negative regulators of the
TGFβ signally through their interaction with Smad4, as
reported in vertebrates (Wu et al., 2003). In Drosophila, Dac
does not seem to have a function in the wing blade, but is able toproduce ectopic eyes when co-expressed with eyes absent
(Chen et al., 1997; Hammond et al., 1998). The representative
of the Ski/Sno proteins in C. elegans, Dac-1, belongs to this
subfamily. Daf-5, previously reported as Ski/Sno homologue,
shows conservation in the Smad4-binding domain but it lacks
the Ski domain (da Graca et al., 2004; Takaesu et al., 2006). The
CG11093 family (also called Iceskate; da Graca et al., 2004),
which is poorly characterized, includes two subfamilies in
vertebrates. In humans, the closer homologue to CG11093 is
Fussel-18, which is expressed exclusively in the nervous system
and interacts with Smad2 and 3 (Arndt et al., 2005). Closely
related is the Ladybird homeobox corepressor 1 (LBXCO1)
subfamily, whose homologue in mice, Corl1, is expressed
exclusively in brain and testis and interacts with the Ladybird
homeobox protein (Arndt et al., 2005; Mizuhara et al., 2005).
These data indicate that Drosophila has representative ortho-
logues for the three branches of the Ski superfamily, but a
unique member belonging to the Ski/SnoN family (Fig. 3A).
Fig. 3. Phylogenetic analysis of the Ski superfamily. (A) Unrooted dendogram showing three main branches: in blue, the Ski/Sno family that includes CG7233 from
Drosophila (Ski domain consensus RLCLPQ); in orange, the Dachshund family that includes the only C. elegans homolog Dac-1 (consensus LICLPQ); in purple, the
CG11093-like family that includes also the LBXCO1 members (consensus RLCLAQ). See also Supplementary Fig. 1. (B, C) Alignments of the Ski domain (B) and
the Smad4-binding domain (C) from the Ski/Sno family members. Red arrows indicate the amino acid changes identified in seven dsnoNmutants isolated as GS-M67
revertants. Ag, A. gambiae; Ce, C. elegans; Dm, D. melanogaster; Dp, D. pseudoobscura, Dr, zebrafish; Gg, chicken; Hs, human; Mm, mouse; LBXCO1: Ladybird
homeobox corepressor 1.
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Vertebrate Ski/SnoN proteins have been extensively char-
acterized by biochemical and cell culture approaches, behaving
as strong antagonists of the Activin and BMP signaling
pathways (see Introduction). The phenotype caused by
increased expression of dsnoNS suggests that such antagonism
is conserved in Drosophila. To understand the molecular bases
of this interaction, we monitored the effects of dsnoN over-
expression on the expression of several Dpp targets in the wing
imaginal disc. We used target genes that are activated by Dpp
signaling such as dad (Tsuneizumi et al., 1997), spalt (sal)
(Barrio and de Celis, 2004; de Celis et al., 1996), optomotorblind (omb) (Grimm and Pflugfelder, 1996; Sivasankaran et al.,
2000) and blistered (bs) (Nussbaumer et al., 2000), as well as
brk, which expression is repressed by Dpp activity (Campbell
and Tomlinson, 1999; Jazwinska et al., 1999; Minami et al.,
1999). We compared the effects of dSnoN with those of the Brk
repressor and the Dpp antagonist Dad (Fig. 4). We found that
increased expression of dsnoN reduces the expression of Sal
(Fig. 4B) and dad (Fig. 4BIII) with high efficiency and also
interferes with the expression of omb and Bs (Figs. 4BI and
BII). In addition, the expression of brk, normally restricted to
the most anterior and posterior part of the wing blade by Dpp
repression, is now observed throughout the wing blade (Fig.
4BIV). These effects are very similar to those of ectopic Dad or
Fig. 4. Effects of dSnoN, Dad and Brk on the expression of Dpp targets in wing discs. (A–AV) Wild-type third instar wing discs showing the expression of Sal (A),
omb-lacZ (AI), Bs (AII), dad-lacZ (AIII) and brk-lacZ (AIV). Gal4-sal/GS-M67 (B–BIV), Gal4-sal/UAS-brk (C–CIV) and Gal4-sal/UAS-dad (D–DIV) third instar wing
showing the expression of Sal (B–D), omb-lacZ (BI, CI, DI), Bs (BII, CII, DII), dad-lacZ (BIII, CIII, DIII) and brk-lacZ (BIV, CIV, DIV). (AV–DV) Adult wings of wild-type
(AV), Gal4-sal/GS-M67 (BV), Gal4-sal/UAS-brk (CV) andGal4-sal/UAS-dad (DV) genotype. (E) Wild-type expression of dpp-lacZ (green) and Sal (red) in third instar
wing disc. Individual green channel is shown in panel EI. (F) Expression of dpp-lacZ (green) and Sal (red) in sal-Gal4/GS-M67 third instar wing imaginal discs.
Individual green channel is shown in panel F′. (G–GII) Reduction of Sal expression (red in panels G and GII) in the dorsal side of a third instar wing disc containing a
clone of cells expressing dSnoN (green in panels G and GI).
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target gene is affected (Figs. 4C–CIV for Brk and Figs. 4D–DIV
for Dad). Thus, Brk is more efficient than Dad or dSnoN in
repressing omb (Figs. 4CI, DI and BI) and bs (Figs. 4CII, DII and
BII), and dSnoN is more efficient that Dad or Brk in repressing
dad (Figs. 4BIII, DIII and CIII). Ectopic expression of dSnoN,
Dad or Brk interfered the repression of brk in the center of the
wing blade with similar efficiency (Figs. 4BIV, DIV and CIV).
The phenotype of the corresponding wings for these combina-
tions is similar, despite the differences observed in expression
patterns in the imaginal disc (Figs. 4BV, CV and DV). The
expression of dpp in wing discs where dSnoN is over-expressed
is normal (Figs. 4E–F), and the effects of dSnoN over-
expression on Sal are cell autonomous (Fig. 4G). These data
indicate that dSnoN antagonizes Dpp targets gene expression,
acting both on genes that are normally activated (sal, dad, omb
and bs) or repressed (brk) by Dpp signaling. Because Mad/Med
contribute to both activation and repression of Dpp targets(Muller et al., 2003), it is likely that the effect of dSnoN is
exerted on the formation or activity of Mad/Med complexes.
dSnoNS does not modify Mad phosphorylation, but titrates
Mad/Med activity
To further characterize the relationship between dSnoN and
the Dpp pathway, we analyzed genetic combinations between
dSnoN and several members of the pathway in misexpression
experiments. Ectopic expression of activated-Tkv (Tkv*) or
activated-Babo (Babo*) in the center of the wing, the domain
where the Dpp pathway is normally active, modifies wing size,
the pattern of veins and the integrity of the wing (Fig. 5AI,II). In
contrast, ectopic expression of Mad, Med or dSmad2 in the
same central domain does not modify severely wing growth or
patterning (Fig. 5AIII–V). The co-expression of dSnoN rescues
the phenotypes caused by ectopic Tkv* or Babo* (Fig. 5BI,II)
resulting in wings very similar to those over-expressing only
Fig. 5. Genetic interactions between dSnoN and different members of the Dpp pathway. (A) Adult wings of combinations between the Gal4 line Gal4-sal and the UAS
lines UAS-tkv* (AI), UAS-babo* (AII), UAS-Med (AIII), UAS-Mad (AIV) and UAS-dSmad2 (AV). (B) Adult wings co-expressing dSnoN and different members of the
Dpp pathway in the sal domain of expression, Gal4-sal, GS-M67/UAS-tkv* (BI), Gal4-sal, GS-M67/UAS-babo* (BII), Gal4-sal GS-M67/UAS-Med (BIII), Gal4-sal
GS-M67/UAS-Mad (BIV) and Gal4-sal GS-M67/UAS-dSmad2 (BV). (C) Adult wings over-expressing in the entire wing blade (Gal4-nub) different members of the
Dpp pathway. UAS-tkv* (CI), UAS-babo* (CII), UAS-Med (CIII), UAS-Mad (CIV) and UAS-dSmad2 (CV). (D) Adult wings co-expressing dSnoN and different
members of the Dpp pathway in the nub pattern of expression. Gal4-nub, GS-M67/UAS-tkv* (DI), Gal4-nub, GS-M67/UAS-babo* (DII), Gal4-nub, GS-M67/UAS-
Med (DIII), Gal4-nub, GS-M67/UAS-Mad (DIV) and Gal4-nub, GS-M67/UAS-dSmad2 (DV). (E–K) PMad expression in third instar wing imaginal discs from wild-
type (E) or from the genetic combinations Gal4-nub/GS-M67 (F), Gal4-nub/UAS-tkv* (G), Gal4-nub/UAS-dad (H), Gal4-nub, GS-M67/UAS-tkv* (I), Gal4-nub, GS-
M67/UAS-dad (J) and higher magnification of the dorsal side of a salGal4 GS-M67/UAS-tkv* (K).
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functions downstream of the activated receptors. In contrast, the
expression of Mad or Med suppresses the phenotype of dSnoN,
giving rise to wings of almost normal size and pattern (Fig.
5BIII,IV), suggesting that dSnoN titrates functional Mad/Med
complexes. Similar results were obtained when the ectopic
expression was driven in the entire wing, including the
territories where the Dpp pathway is not normally active.
Thus, the combination of nub-Gal4 with UAS-tkv* or UAS-
babo* causes the differentiation of most wing cells as vein
tissue (Fig. 5CI–II), and the simultaneous expression of dSnoN
efficiently suppresses these phenotypes (Fig. 5DI–II). The over-
expression of Mad or Med in all wing cells caused a mutant
phenotype consisting of alterations in the vein pattern and wing
size (Fig. 5CIII–IV). The co-expression of Mad and dSnoN
results in wings with a normal pattern of veins (Fig. 5CIV),
whereas the phenotype of ectopic Med (Fig. 5CIII) is retained
when dSnoN is also over-expressed (Fig. 5DIII), indicating that
(1) Mad and Med are able to suppress dSnoN, and (2) dSnoN
reduces the activity of Mad. Ectopic expression of dSmad2 in
all wing cells only causes a weak increase in wing size (Fig.5CV). Interestingly, we found a strong synergistic interaction
between dSnoN and dSmad2, consisting in the generation of
very small wings without veins, similar to those of strong dpp-
disc alleles (Fig. 5DV, compare with Fig. 1E). Possibly, the
formation of Med/dSmad2 dimers reduces the formation of
Mad/Med functional dimers, already severely compromised by
the presence of dSnoN (see Discussion).
The genetic interactions between dSnoN and the elements
of the Dpp and Activin pathways can be interpreted as a
consequence of sequestering Mad or Med by dSnoN or,
alternatively, by the failure to phosphorylate Mad in the
presence of dSnoN. We studied in vivo the distribution of
phosphorylated-Mad (PMad) in the presence of dSnoN or Dad,
which is known to interfere with Mad phosphorylation
(Tsuneizumi et al., 1997; Figs. 5E–K). When dSnoN ex-
pression is increased, Mad is still phosphorylated and localized
preferentially in the nucleus, although the pattern of PMad
accumulation is not completely normal, appearing with a less
complete nuclear localization (compare Figs. 5E and F). Mad
phosphorylation is also detected in the nucleus at higher than
normal levels upon dSnoN over-expression in the presence of
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the wing disc, dSnoN does not prevent Mad phosphorylation,
suggesting that interactions between dSnoN and Med or PMad
underlie the negative effects of dSnoN on Dpp signaling.
Generation and analysis of dsnoN loss of function alleles
We have shown that over-expression of dSnoN interferes
with Dpp signaling probably through interactions with PMad
and/or Med. In order to analyze the requirement of the gene
during normal development, we generated a deficiency that
removes all dsnoN coding sequences, as well as several point
mutations that prevent the negative regulation of Dpp
signaling. The dsnoN deficiency is a 65 kb deletion induced
by FRT-based recombination between the insertions f00844
and d02797 and includes the genes dsnoNS, most of dsnoNL,
CG7231 and most of CG7228 (Supplementary Fig. 1).
Homozygous flies Df(2L)snoN are homozygous viable, albeit
the viability is only of 30%. The surviving flies have wings of
normal size and pattern, and the females are sterile.
Furthermore, the expression of Sal and PMad is not affected
in homozygous Df(2L)snoN wing imaginal discs (data not
shown and Supplementary Fig. 1). These data contrast with the
recent report that dSno loss of function mutations cause post-
embryonic lethality (Takaesu et al., 2006). The lethal allele
used in this study, l(2)sh1402 (Oh et al., 2003), is fully viable
over our deficiency. The lethality of l(2)sh1402 was
interpreted as due to the deletion of a 297 family transposable
element in these flies (Takaesu et al., 2006). However, we also
did not find this insertion in GS-M67 flies, and this line is a
fully homozygous viable.Fig. 6. Identification and characterization of dsnoN mutants. (A) Representation of t
binding domain (Smad4, red). The amino acid substitutions present in each mutant p
acids. (B–J) Adult wings of combinations between Gal4-638 and all GS-M67 reve
Gal4-638/GS-M67F3, (E) Gal4-638/GS-M672C3, (F) Gal4-638/GS-M67R102, (G) Gal
638/GS-M67K2. Below each wing is shown the position of the corresponding amino a
GS-M672C3 over-expression. (K) Gal4-nub/UAS-Mad, (L) Gal4-nub/GS-M67; UAS-Point mutation alleles in the dsnoN coding region were
induced by chemical mutagenesis as revertants of the GS-M67
insertion, taking advantage of the strong dpp-like phenotype of
the combination Gal4-638/GS-M67 (see Fig. 1D). Three out of
the nine mutants isolated and mapped to the coding region of
dsnoN, M673K1, M672C3 and M673W1 behave as complete
revertants (Figs. 6C, E, H). M672C3 is caused by an F234I
substitution in the dSnoNS region corresponding to the Smad4-
binding domain of vertebrate Ski (Fig. 3C; Fig. 6A).
Interestingly, this phenylalanine is important to establish
hydrogen bounds with several amino acids in Smad4 (Wu et
al., 2002), suggesting that the 2C3 mutant protein has reduced
ability to interact with Med/Smad4. The dSnoN2C3 protein is
still able to cancel, albeit more inefficiently than the wild-type
protein, some of the effects of ectopic Mad expression when
over-expressed (Figs. 6K–M). M673W1 (H273Q) also maps in
the Smad4-binding domain of dSnoN, andM673K1 corresponds
to an I126N substitution in the Smad2/3 interacting domain
identified by Ueki and Hayman (2003). We also identify four
partial revertants causing amino acid substitutions in the Med/
Smad4-binding domain (R102: S247F; S2: V269M; and V2:
E277K; Fig. 3C and Fig. 6A) and other partial revertants
mapping in the Ski domain (F3: I182T; Fig. 3B and Fig. 6A),
the N-terminal region (1D1; P71S; Fig. 6B) and the C-terminal
region of dSnoNS (K2: E329K; Fig. 6J), suggesting that these
regions are also important for dSnoN activity. The C-terminal
sequence of dSnoNS (ELEHKKRKVRWV) includes a putative
consensus nuclear localization signal. However, no major
differences were found between the subcellular localization of
dSnoNS-GFP or dSnoNSΔC-GFP, a fusion protein that lacks
the C-terminal part of the protein (see below). All revertantshe dSnoNS protein, showing the Ski domain (Ski/Sno, orange) and the Smad4-
rotein are shown. Numbers correspond to the localization of the affected amino
rtant chromosomes: (B) Gal4-638/GS-M671D1, (C) Gal4-638/GS-M673K1, (D)
4-638/GS-M67S2, (H) Gal4-638/GS-M673W1, (I) Gal4-638/GS-M67V2, (J) Gal4-
cid substitution as black lines. (K–M) Partial rescue of Mad over-expression by
Mad/+, (M) Gal4-nub/GS-M672C3; UAS-Mad/+.
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(see Figs. 3B and C), and we did not find any revertant in the
non-conserved dSnoNL unique C-terminal region. These data
suggest that the effect of dSnoNS over-expression on Dpp
signaling requires an intact Smad4-interacting domain, the Ski
region and the integrity of the dSnoNS C-terminal domain.
All GS-M67 revertant chromosomes were lethal in homo-
zygosis, although the lethality is not related to mutations inFig. 7. Subcellular localization of dSnoNS-GFP in wing discs. (A) Representation o
domain (orange), and the Smad4 (red)- and Smad2/3 (blue)-binding domains report
Amino acids VRWV (underlined in purple) are spliced out in dSnoNL. (B–E) Adult
C); Gal4-nub/UAS-dsnoNSΔC-GFP (dSnoNSΔC-GFP; D) and Gal4-nub/UAS-dsnoN
discs showing GFP expression (green). (F–F′) High magnification of the central regio
in panels F and F′) and Osa (red in panel F). (G–G′) High magnification of the centr
(green in panels G and G′) and Sal (red in panel G). (H–H′) Expression of GFP (gree
disc. (I–I″) Expression of GFP (green in panels I and I′) and PMad (red in panels I a
GFP (green in panels J–J′) and Blister (red in panel J″) in a Gal4-nub/UAS-dsnoNS-
Gal4-sal/UAS-dsnoNS-GFP disc showing expression of phospho-Histone3 (red). (L
dsnoNS-GFP; UAS-Mad/+ (L) genotype. The expression of PMad is shown in red in
nub/UAS-dsnoNS-GFP; UAS-tkv*/+ (L) genotype. (N–N′) High magnification of th
genotype. The expression of PMad is shown in red in panel N′.dsnoN but to second site mutations. Thus, (1) all pair-wise
combinations between GS-M67 revertants are viable and lack a
visible phenotype, (2) heterozygous between these revertants
and the Df(2L)snoN are fully viable. Trans-heterozygous
females between any dsnoN revertant and Df(2L)snoN are
fertile and complete oogenesis normally, indicating that the
sterility observed in Df(2L)dsnoN homozygous females cannot
be attributed to dSnoN interactions with Mad/Med complexes.f the different dSnoN-GFP fusion proteins. Colored lines indicate the Ski/Sno
ed in the vertebrate homologues. The C-terminal peptide is underlined in blue.
wings of the following genotypes: wild-type (WT; B), Gal4-nub/GS-M67 (M67;
SGFP (dSnoNS-GFP; E). (F–N) Confocal pictures of third instar wing imaginal
n of a Gal4-sal/UAS-dsnoNS-GFPwing disc showing expression of GFP (green
al region of a Gal4-nub/UAS-dsnoNSΔC-GFP disc showing expression of GFP
n in panels H and H′) and Sal (red in panel H) in a Gal4-nub/UAS-dsnoNS-GFP
nd I″) in a Gal4-nub/UAS-dsnoNS-GFP; UAS-Mad/+ disc. (J–J″) Expression of
GFP; UAS-Med/+ wing disc. (K) High magnification of the central region of a
–L′) High magnification of the central region of a wing disc of Gal4-nub/UAS-
panels L and L′. High magnification of the dorsal region of a wing disc of Gal4-
e central region of a wing disc of Gal4-nub/UAS-dsnoNS-GFP; UAS-Mad/+ (L)
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and viable heteroallelic combinations of dad alleles (data not
shown).
Subcellular localization of dSnoN in imaginal discs
We generated dSnoN-GFP fusion proteins and studied their
phenotypes and subcellular localizations when over-expressed
in the wing imaginal disc (Fig. 7). Ectopic expression of full-
length dSnoNS-GFP causes a phenotype of wing size reduction
and vein loss very similar to the over-expression of dSnoN
(Figs. 7C and E), suggesting that the fusion protein is fully
functional. In contrast, ectopic expression of dSnoNSΔC-GFP,Fig. 8. Differential subcellular localization of dSnoN in cultured cells and its effect
Cos1 cells transfected with the indicated constructs. Nuclei are stained with DAPI (no
in the absence (A, C, E, G) or presence (B, D, F, H) of Tkv*. (I–J) Cells were transfect
representations of times of activation of TLX2-Lux (K) and percentage of viable ce
values are shown. Bars indicate standard deviation.lacking the last 22 C-terminal amino acids of dSnoNS (Fig. 7A),
only causes a weak loss of L4 vein without affecting wing size
(Fig. 7D), suggesting that this protein has lost most activity. The
level of GFP expression in the combination Gal4-nub/UAS-
GFP was very similar in all wing cells during the third larval
instar (data not shown). In contrast, we found that the levels and
subcellular localization of the GPF signal were extremely
heterogeneous within each wing disc in Gal4-nub/UAS-
dsnoNS-GFP (Fig. 7F) and Gal4-nub/dsnoNSΔC-GFP (Fig.
7G). In general, the protein is localized in both the nucleus and
the cytoplasm, but the levels of GFP in these cellular
compartments vary in different cells. In addition, GFP cannot
be detected in cells distributed homogeneously in clusterson transcriptional activation and cell viability. (A–J) Immunocytochemistry on
t shown) and outlined in yellow. (A–H) Cells were transfected with dsnoNS-GFP
ed with dsnoNL-GFP in the absence (I) or presence (J) of Tkv*. (K, L) Graphical
lls (L) in P19 cultures (Y axes) in the presence of the indicated constructs. t-test
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dSnoNS-GFP is not obviously related to the pattern of mitosis
because the distribution of phospho-Histone3, a marker of
mitosis, is not related to the expression of dSnoNS-GFP (Fig.
7K). Furthermore, we did not find any correlation between the
pattern of dSnoNS-GFP expression and the domain of
endogenous Dpp activity, as monitored by PMad or Sal
expression (Figs. 7H, I–I″). These data indicate that, in our
experimental settings, endogenous Dpp signaling does not
interfere with the stability and subcellular localization of
dSnoNS-GFP. Expressing Tkv* does not modify the distribu-
tion of dSnoNS-GFP, although nuclear PMad is now detected at
higher levels (Fig. 7M). As expected from this result, ectopic
expression of Mad and dSnoNS-GFP did not change the
subcellular localization of dSnoNS-GFP or PMad (Figs. 7I–I′,
L–L′). In contrast, when dSnoNS-GFP was co-expressed with
Med, we found that most of the GFP signal is retained in the
cytoplasm (Figs. 7J–J′). This observation suggests that Med
interacts with dSnoNS, forming complexes that are preferen-
tially localized in the cytoplasm. This interpretation is in
agreement with the finding of strong interactions between
dSnoN and Med (Takaesu et al., 2006).
Subcellular localization and activity of dsnoN in cultured cells
To better understand the regulation of dSnoN subcellular
localization, we introduced dSnoN-GFP fusion proteins into
mammalian cells with or without other components of the Dpp
pathway (Fig. 8). When dSnoNS-GFP is introduced alone, the
protein appears both in the nucleus and the cytoplasm and this
distribution does not change in the presence of Mad (Figs. 8A,
E). However, when transfected together with Med, dSnoNS-
GFP is retained in the cytoplasm (Fig. 8C), as it has been
reported for Med alone (Wisotzkey et al., 1998). When Med is
present, the nuclear localization of dSnoNS-GFP is recovered
only when the Dpp pathway is active in the presence of Mad
(Fig. 8H, compare to D and G). These results suggest that
dSnoNS interacts with Med in the cytoplasm, as observed in the
wing disc, and translocates to the nucleus together with Med and
Mad when the pathway is active. Our results do not suggest any
interaction between dSnoNS and Mad. Whether this interaction
exists or not, its nature seems to be weaker than the interaction of
dSnoNSwithMed, as in the presence ofMad andMed, dSnoNS is
still retained in the cytoplasm (Figs. 8G and H). Interestingly, no
major differences were seen in the localization of dSnoNSΔC-
GFP with respect to dSnoNS-GFP (data not shown), suggesting
that the C-terminal region is not necessary for the nuclear
localization of the protein or for its interaction with Med.
dSnoNL-GFP behaves differently than dSnoNS-GFP and is
always retained in the nucleus independently of the presence of
Med or the activation of the Dpp pathway (Figs. 8I and J).
To understand the functionality of the dSnoN isoforms, we
performed transcriptional assays using the mammalian TLX2
responsive element next to the luciferase reporter gene. This
construction has been shown to respond to the Drosophila
homologues of the TGFβ pathway (Brummel et al., 1999; Tang
et al., 1998). The reporter is moderately activated in thepresence of Tkv*, Mad and Med, but this activation diminishes
significantly (P value less than 0.05) when either dSnoN
isoform is introduced in the culture (Fig. 8K). These results
indicate that the dSnoN proteins are able to inhibit the activation
of a TGFβ responsive element in cell culture. The TGFβ
pathway inhibits cellular growth, probably through the inhibi-
tion of cell proliferation (Huang and Huang, 2005). When added
to P19 cells, Tkv*, Mad andMed decrease cell viability by more
than 40% (Fig. 8L). However, this inhibition is counteracted
significantly by the addition of either of the dSnoN isoforms,
probably due to the presence of the Ski and the Smad4-binding
domains present in the three isoforms (Fig. 8L). Taken together,
these results suggest that dSnoN proteins can counteract the
activities of the Dpp pathway in cultured cells, although in vivo
only dSnoNS is capable to inhibit Dpp.
Discussion
We report here the characterization of the Drosophila
homologue to vertebrates Ski and SnoN, and its relationships
to Dpp signaling. dsnoN is transcribed into two isoforms,
dsnoNS and dsnoNL, with dSnoNS being able to interfere with
Dpp signaling when expressed at levels higher than normal in
imaginal discs. These effects of dSnoNS are suppressed by
increasing the expression of either Mad or Med, suggesting that,
when over-expressed, dSnoNS titrates out Mad/Med complexes
and renders them non-functional. In this manner, the antagon-
ism of dSnoN on Dpp signaling affects indiscriminately Dpp
targets that are activated (dad, sal, bs and omb) or repressed
(brk) by the pathway. The elimination of dSnoNS and dSnoNL
by a genetic deficiency did not affect Dpp signaling in the
imaginal discs. This result is surprising because Ski/SnoN are
among the best-known negative regulators of BMP and TGFβ
signaling in vertebrate cells and several molecular mechanisms
linking Ski/SnoN and the Smad proteins have been identified
(see Introduction). Interestingly, the overwhelming majority of
studies relating Ski/SnoN to BMP and TGFβ signaling
pathways are based in experiments where Ski and/or SnoN
are over-expressed (Luo, 2004). Our work shows that the ability
of Ski/Sno to antagonize BMP signaling is conserved in Dro-
sophila and vertebrate cell lines, but brings the physiological
significance of these effects during normal development into
question.
dSnoNS effects on Dpp signaling depend on its Mad- and
Med-binding domains
All the defects we observed in imaginal discs and adult
patterns after increased expression of dSnoNS can be
constructed as the result of reduced Dpp signaling. Thus, the
phenotypes of dsnoNS over-expression are extremely similar to
those characteristics of dpp loss of function mutations, and the
expression of Dpp target genes, but not of dpp itself, is severely
impaired upon dsnoNS ectopic expression. Finally, the inter-
ference with Dpp target expression and the mutant phenotypes
characteristic of increased dSnoN depend on the integrity of its
Mad- and Med-binding domains. We could not observe strong
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indicating that the pathway is not affected from receptor
activation to Mad phosphorylation. Furthermore, ectopic
expression of dSnoN cancels the effects of activated Tkv,
while augmented levels of either Mad or Med cancel the effects
of ectopic expression of dSnoN. These results suggest that
dSnoN interacts with PMad and Med proteins, preventing them
from forming functional complexes. The subcellular location of
dSnoNS-GFP in wing disc cells and cultured mammalian cells
is compatible with direct interaction of dSnoNS with Med
because these proteins are efficiently retained together in the
cytoplasm. However, our results do not support the direct
interaction between dSnoN and Mad, which is in concordance
with immunoprecipitation data (Takaesu et al., 2006). The
importance of dSnoNS interactions with Med is highlighted by
the genetic interactions we observed between dSnoNS and the
Activin pathway members Babo* and dSmad2. Therefore, we
suggest that dSnoNS over-expression interferes with both the
Dpp and Activin pathways, which share Med as a partner for
Mad and dSmad2, respectively (Brummel et al., 1999).
Interestingly, Takaesu et al. reported a function of dSnoN as a
mediator of Activin signaling by enhancing the affinity of
Medea for dSmad2 (Takaesu et al., 2006). However, our dsnoN
mutants and deficiency behave significantly different to those
used by these authors.
In vertebrates, it appears that Ski/SnoN binds R-Smads
(Smad2–3 and Smad1–5) and Smad4 independently, using
different domains in the Ski protein (He et al., 2003; Ueki and
Hayman, 2003;Wang et al., 2000;Wu et al., 2002). It is not clear,
however, whether mutations in both the R-Smad and Smad4 Ski-
interacting domains are needed to suppress Ski/SnoN activities.
Thus, in some assays, removing Smad4–Ski interactions is
enough to cancel the effects of Ski on TGFβ (Suzuki et al., 2004)
or BMP signaling (Takeda et al., 2004), whereas other reports
suggest that Ski proteins defective in binding to only Smad2/3 or
Smad4 retain their activity (He et al., 2003; Ueki and Hayman,
2003; Wu et al., 2002). We observed that most dsnoN mutants
that compromise the ability of the dSnoN to interfere with Dpp
signaling map to the Med/Smad4-binding domain, which is
compatible with an absolute requirement of this domain to
antagonize the pathway. In addition other dSnoN revertants map
to the Ski domain, and one of them (dsnoN3K1) is localized in a
dSmad2/Smad2–3-binding domain identified by Ueki and
Hayman, (2003). In this manner, our in vivo data support the
key role of the Smad4-binding site on dSnoNS to antagonize
Dpp signaling, but suggest that other parts of the protein are also
important to effectively suppress the pathway.
dSnoN subcellular location
The subcellular localization of Ski proteins varies in different
cell types and physiological situations. In most cases, Ski has
been reported as a nuclear protein, although it can be kept in the
cytoplasm, restricting TGFβ signaling by Smad2 sequestration
(Kokura et al., 2003). In mouse liver hepatocytes, C184M, a
small leucine-rich protein that represses growth cell inhibition
by TGFβ, could also retain Ski in the cytoplasm (Kokura et al.,2003). In pre-invasive melanomas Ski is located only in the
nucleus while it appears in the cytoplasm in primary invasive
and metastatic melanomas (Reed et al., 2001). SnoN is
predominantly cytoplasmic in normal tissues and in non-
tumorigenic or primary epithelial cells. After cell-cycle arrest,
SnoN translocates into the nucleus (Krakowski et al., 2005). In
the Drosophila wing disc the localization of the dSnoN-GFP
fusion protein when over-expressed occurs in both the nucleus
and the cytoplasm, and this pattern appears independent of Dpp
signaling because it does not correlate with the spatial domain
of Dpp activation (PMad expression). In mammalian cells,
however, the location of dSnoNS can be modulated by the
activation of the Dpp pathway, mainly through the interaction of
dSnoNS with Med, a situation also observed in the wing disc
uponMed over-expression. We propose that in cultured cells the
phosphorylation of Mad by Tkv* promotes its translocation to
the nucleus accompanied by Med, which in turn transport
dSnoNS. Taking dSnoNS to the nucleus along with the
activated Smads could ensure the down-regulation of the
pathway to avoid an excess of signal. In the wing disc, in
contrast, dSnoS-GFP does not re-localize appreciably to the
nucleus in the presence of PMad. The different response to
PMad observed in the wing disc and in cultured cells might be
due to different relative levels of dSnoNS-GFP, Mad and Med
expression generated in the two experimental systems because
in cell culture experiments all three genes are expressed using
similar promoters, whereas in wing discs dSnoN-GFP is
expressed using the Gal4/UAS system. Alternatively, additional
mechanisms could contribute to dSnoNS subcellular localiza-
tion in the wing disc, as we observed that unidentified Dpp-
independent mechanisms modify the stability of the fusion
protein.
Developmental role of dSnoN in Drosophila
Despite the fact that the wing is an excellent system to
demonstrate the capacity of dSnoNS to antagonize the Dpp
pathway, our genetic analysis does not reveal a role of this
protein during normal wing patterning. To explain the lack of a
prominent function for dSnoNS in the wing, we could argue that
dSnoNS function is carried out by another homologue of the Ski
superfamily in Drosophila (see Fig. 3). However, we think this
is unlikely. Dac is not expressed in the wing blade, except in
some cells at the wing margin, and it does not seem to have a
requirement there (Mardon et al., 1994). However, similarly to
dSnoNS, Dac is also able to interfere with wing development in
over-expression experiments (Chen et al., 1997). Furthermore,
CG11093 is not a likely candidate as it is not expressed in the
wing imaginal disc. In the case of its mammalian counterparts,
its expression seems to be restricted to the nervous system.
Alternatively, a requirement for dSnoN during normal wing
development might be hidden due to the existence of
complementary mechanisms that contribute to Dpp signal
down-regulation. However, we failed to observed any effect of
dsnoN mutants and Df(2L)snoN on the phenotype of viable dad
alleles (not shown). In this context, it is remarkable the paucity
of data that relate Ski/Sno activity to BMP/TGFβ signaling in
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related to TGFβ and null mutants are viable and show
cryophilic behavior (Colosimo et al., 2004). In mice, the
analysis of ski or sno mutants show a variety of developmental
defects consistent with their role in various signaling pathways
but it does not immediately relate them to BMP/TGFβ signaling
(Berk et al., 1997; Colmenares et al., 2002).
Although the capacity of Ski proteins to interact directly
with a wide variety of factors (see Introduction) makes
feasible an involvement for these proteins in multiple
developmental pathways, the promotion of oncogenic trans-
formation by Ski or SnoN proteins is related to their capacity
to inhibit the TGFβ pathway (Buess et al., 2004; Poser et al.,
2005; Reed et al., 2001; Zhang et al., 2003; Zhu et al.,
2005). Thus, the function of dSnoNS, which is not apparent
during normal wing development, might be manifested when
Dpp/TGFβ signaling is de-regulated. For example, mice
deficient for ski are more susceptible to generate tumors
when exposed to a chemical carcinogen (Shinagawa et al.,
2001). Although we have failed to reveal such effects for
dSno, it is still possible that this gene was important for cell
behavior in cells where the level of Dpp signaling is strongly
modified.
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